Mortality related to novel psychoactive substances in Scotland, 2012: An exploratory study

Highlights • Deaths involving novel psychoactive substances (NPS) affect small numbers at population level. • High incidence of NPS is noteworthy when considering DRDs within known drug user populations. • Deaths rarely involve NPS alone and typically involve a range of other substances. • The major...

Full description

Saved in:
Bibliographic Details
Published in:The International journal of drug policy 2015-05, Vol.26 (5), p.461-467
Main Authors: McAuley, Andrew, Hecht, Garry, Barnsdale, Lee, Thomson, Catherine S, Graham, Lesley, Priyadarshi, Saket, Robertson, J. Roy
Format: Article
Language:English
Subjects:
Adult
Benzodiazepines - adverse effects
Drug Overdose - mortality
Drug policy
Drug use
Drugs
Female
Humans
Internal Medicine
Male
Males
Medical Education
Mortality
Novel psychoactive substances
Overdose
Psychotropic Drugs - adverse effects
Scotland - epidemiology
Stimulants
Substance-Related Disorders - mortality
Toxicology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Deaths involving novel psychoactive substances (NPS) affect small numbers at population level. • High incidence of NPS is noteworthy when considering DRDs within known drug user populations. • Deaths rarely involve NPS alone and typically involve a range of other substances. • The majority of deaths involved Benzodiazepine-type NPS drugs, mainly Phenazepam. • Differences in the profile of deaths involving Benzodiazepine and Stimulant-type NPS emerged.
ISSN:0955-3959
1873-4758
DOI:10.1016/j.drugpo.2014.10.010